Dihydroquercetin Nanomicelles Mitigate Hippocampal Apoptosis and Alleviate Autism-Like Behaviors in ASD Rats via the IKK/IKB/NF-κB Signaling Pathway
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Shan Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin 150086, China. Hauptthemen laut MEDLINE: Quercetin, Apoptosis, Hippocampus, Autism Spectrum Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Regional Joint Fund of National Natural Science Foundation of China.
Abstract (Originalsprache)
Dihydroquercetin (DHQ), a compound with neuroprotective effects, has shown its potential in a variety of nervous system diseases. However, its mechanism of action in autism spectrum disorder (ASD) remains to be further explored. Due to its poor solubility, the clinical application of DHQ is restricted. In this study, we aimed to improve the solubility of DHQ by constructing a novel nanodrug delivery system. We utilized the amphiphilic block copolymer MANNOSE-PEG2000-DSPE to encapsulate DHQ, and the resulting formulation was abbreviated as MAN@DHQ. The ASD rats were treated with MAN@DHQ for 7 days. The results of in vivo experiments confirmed that MAN@DHQ could effectively alleviate autism-like behaviors of ASD rats. Western blot results demonstrated that MAN@DHQ mitigate hippocampal apoptosis and ameliorated neuronal damage in the hippocampus of ASD rats via the IKK/IKB/NF-κB signaling pathway. The therapeutic potential of MAN@DHQ in ASD treatment represents a paradigm-shifting advancement in autism pharmacotherapy and offers promise for clinical interventions for ASD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin 150086, China.
- Key Laboratory of Precision Nutrition And Health, Ministry of Education, Harbin Medical University, Harbin 150086, China.
- Heilongjiang Province Key Laboratory of Child Development and Genetic Research, Harbin Medical University, Harbin 150086, China.
- Department of Pharmaceutics, Harbin Medical University-Daqing Campus, 1 Xinyang Rd, Daqing 163319, China.
- Department of Developmental Behavioral Pediatrics, The Sixth Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
ORCID-Profile: Changmei Zhang
Förderung
- Regional Joint Fund of National Natural Science Foundation of China
Zitieren
APA
Zhao, S., Chen, X., Sun, Q., Zhu, H., Yang, S., Song, X., Chen, J., Zhang, C., & Wu, L. (2025). Dihydroquercetin Nanomicelles Mitigate Hippocampal Apoptosis and Alleviate Autism-Like Behaviors in ASD Rats via the IKK/IKB/NF-κB Signaling Pathway. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00422
Vancouver
Zhao S, Chen X, Sun Q, Zhu H, Yang S, Song X, et al. Dihydroquercetin Nanomicelles Mitigate Hippocampal Apoptosis and Alleviate Autism-Like Behaviors in ASD Rats via the IKK/IKB/NF-κB Signaling Pathway. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00422
BibTeX
@article{Zhao2025,
author = {Zhao, Shan and Chen, Xiaotong and Sun, Qiong and Zhu, Haiyan and Yang, Sen and Song, Xueting and Chen, Jingyi and Zhang, Changmei and Wu, Lijie},
title = {Dihydroquercetin Nanomicelles Mitigate Hippocampal Apoptosis and Alleviate Autism-Like Behaviors in ASD Rats via the IKK/IKB/NF-κB Signaling Pathway},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00422}
}
EUVIMED